Quality of life and productivity loss in patients with ankylosing spondylitis using tumor necrosis factor inhibitors

Int J Rheum Dis. 2023 Jul;26(7):1412-1413. doi: 10.1111/1756-185X.14607. Epub 2023 Mar 20.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Humans
  • Quality of Life
  • Spondylitis, Ankylosing* / diagnosis
  • Spondylitis, Ankylosing* / drug therapy
  • Tumor Necrosis Factor Inhibitors / adverse effects
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor Inhibitors
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha